atrasentan has been researched along with Diabetes Mellitus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandez-Fernandez, B; Ortiz, A | 1 |
| de Zeeuw, D; Heerspink, HJL; Parving, HH | 1 |
| Dhaun, N; Heerspink, HJL; Kohan, DE; Smeijer, JD; Webb, DJ | 1 |
| Batu Demir, D; Cooper, ME | 1 |
2 review(s) available for atrasentan and Diabetes Mellitus
| Article | Year |
|---|---|
Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease.
Topics: Atrasentan; Diabetes Mellitus; Diabetic Nephropathies; Endothelin Receptor Antagonists; Humans; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2021 |
New strategies to tackle diabetic kidney disease.
Topics: Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Atrasentan; Diabetes Mellitus; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Endothelin Receptor Antagonists; Humans; Hypoglycemic Agents; Kidney Failure, Chronic; Mineralocorticoid Receptor Antagonists; Naphthyridines; Pyrrolidines; Renal Artery; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors; Sympathectomy | 2016 |
2 other study(ies) available for atrasentan and Diabetes Mellitus
| Article | Year |
|---|---|
Atrasentan: The Difficult Task of Integrating Endothelin A Receptor Antagonists into Current Treatment Paradigm for Diabetic Kidney Disease.
Topics: Albuminuria; Atrasentan; Diabetes Mellitus; Diabetic Nephropathies; Endothelin A Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Humans; Pyrrolidines | 2021 |
Atrasentan in patients with diabetes and chronic kidney disease - Authors' reply.
Topics: Atrasentan; Diabetes Mellitus; Diabetic Nephropathies; Humans; Renal Insufficiency, Chronic | 2020 |